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Background. Gene expression levels change to adapt the stress, such as starvation, toxin, and radiation. The changes are signals
transmitted through molecular interactions, eventually leading to two cellular fates, apoptosis and autophagy. Due to genetic
variations, the signalsmaynot be effectively transmitted tomodulate apoptotic and autophagic responses. Such aberrantmodulation
may lead to carcinogenesis and drug resistance. The balance between apoptosis and autophagy becomes very crucial in coping
with the stress. Though there have been evidences illustrating the apoptosis-autophagy interplay, the underlying mechanism and
the participation of the regulators including transcription factors (TFs) and microRNAs (miRNAs) remain unclear. Results. Gene
network is a graphical illustration for exploring the functional linkages and the potential coordinate regulations of genes.Microarray
dataset for the study of chronic myeloid leukemia was obtained from Gene Expression Omnibus. The expression profiles of those
genes related to apoptosis and autophagy, including MCL1, BCL2, ATG, beclin-1, BAX, BAK, E2F, cMYC, PI3K, AKT, BAD, and
LC3, were extracted from the dataset to construct the gene networks. Conclusion. The network analysis of these genes explored the
underlying mechanisms and the roles of TFs and miRNAs for the crosstalk between apoptosis and autophagy.
1. Introduction
Apoptosis is a kind of programmed cell death, which plays
a very important role in maintaining the adult tissue home-
ostasis and supporting the embryonic tissue remodeling
[1]. Besides the proper cell development, external factors,
such as nutrient deprivation, toxin, hypoxia, and radiation,
trigger the mechanism of apoptosis by inducing cellular
stress and subsequent signal transmission throughmolecular
interactions. B-cell CLL/lymphoma 2 (BCL2) homologues
have been extensively studied and experimentally validated
as the key antiapoptotic and proapoptotic regulators that
control the outer membrane permeability or integrity of
mitochondria for the release of cytochrome c [2]. Among
the antiapoptotic BCL2 homologues, BCL2 and BCL-XL
can inhibit the formation of cytochrome c/Apaf-1/caspase-9
apoptosome by binding their unique BH4 domain to the C
terminal of apoptotic peptidase activating factor 1 (Apaf-1)
[3, 4]. The myeloid cell leukemia 1 (MCL1) is another anti-
apoptotic BCL2 homologue whose degradation in response
to the stress through translation inhibition enhances the
activation of apoptosis [2]. However, the whole apoptotic
process cannot be controlled tightly by the high responsive-
ness of MCL1 without the commitment of the downstream
proapoptotic regulators, such as BCL2-associated X protein
(BAX) and BCL2-antagonist/killer (BAK). As proapoptotic
BCL2 homologues, BAX and BAK form homooligomers
within the mitochondrial membrane and breach its integrity,
activating the caspases and apoptosis. These negative and
positive regulations of apoptosis stop the division of damaged
cells selectively and control a viable cell number to reduce the
burden of nutritional supply.
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Autophagy is a catabolic process responding to the stress
induced by the above-mentioned external factors. Different
from apoptosis, autophagy helps the cells to survive and
maintain their functions by eliminating the damaged organ-
elles and recycling the obsolete cytosol. These damaged or
obsolete materials are contained by autophagosome and then
fuse with a lysosome for bulk degradation. The autophago-
some is double-membrane vesicle regulated by a set of
autophagy-related (ATG) genes and nucleated by a protein
complex of beclin-1 and phosphatidylinositol 3-kinase (PI3K)
[5]. BCL2, as mentioned above, an antiapoptotic regulator,
can also inhibit autophagy by binding to beclin-1 at the
endoplasmic reticulum and its dissociation with beclin-1 is
required for inducing autophagy [6]. In the same family,
MCL1 regulates autophagy through its degradation under
stress and interaction with beclin-1 on mitochondria [2].
However, the degradation of MCL1 or the inhibition of
BCL2 is not decisive to activate autophagy without the
fusion between autophagosomes and lysosomes regulated by
lysosomal inhibitors and dissociation with ATG proteins [5,
6]. Thus, the interactions between the upstream and down-
stream molecules, such as beclin-1 and ATG, are also critical
for the activation of autophagy.
The relationship between apoptosis and autophagy
depends on the cellular context. As the mechanisms of apop-
totic and autophagic responses share common pathways but
mutually inhibit each other, the cells may adapt to the stress
with a combination of these responses or in a mutually exclu-
sive manner. The apoptotic response can be postponed or
transformed to the autophagic one when the essential apop-
totic proteins, such as BAX and BAK, are removed or
inhibited [5]. Also, the long-lived differentiated nerve cells
aremore susceptible to autophagy than apoptosis tomaintain
homeostasis under stress [2]. Conversely, the inhibition of
autophagy by the deletion of beclin-1 drives the cells towards
apoptosis. The cells undergo apoptosis when beclin-1, ATG,
or PI3K is inactivated to block the autophagy at an early
stage, or when the lysosomal protein LAMP2 is depleted to
block the fusion of autophagosomes and lysosomes at the late
stage [5]. These evidences support the polarization between
apoptosis and autophagy. On the other hand, apoptosis and
autophagy share the common inducers, which are BCL2
homology-3 (BH3) only proteins, and the common stress
mediators, including reactive oxygen species (ROS), freeCa2+
ions, and ceramide, as well as transcription factor p53, in their
pathways. Thus, the concurrent triggers of both processes
are allowed [5]. Therefore, the cell survival and death have
to be balanced to maintain the normal cell functions and
suppress carcinogenesis. The participation of transcription
factors (TFs) and microRNAs (miRNAs) is crucial to tune
the interplay by imposing changes in the expression of genes
related to apoptosis and autophagy.
Transcriptional regulation is a kind of molecular inter-
actions where the TF coded by a gene binds to a specific
site in the 5󸀠 untranslated region (UTR) of the target gene to
regulate its expression [7]. As the change in the expression of
a TF could be relayed to its target gene through such protein-
DNA binding, transcriptional regulation may account for
the coexpression of TF and target gene [8, 9]. By the same
principle, a gene pair may exhibit correlated expression pro-
files when these two genes are concurrently regulated by a
common TF [8]. The translation process of a gene is regu-
lated by miRNAs, noncoding transcripts of approximately 21
nucleotides long. Through the imperfect base pairing with
a binding site in the 3󸀠 UTR of mRNA, miRNA regulates
the expression of the target gene or destabilizes its mRNA
[10]. It was shown that most of the miRNA-mRNA pairs
exhibit highly correlated expression profiles, though both
negative and positive correlations [11]. It is straightforward
to anticipate the coexpression of two target genes, which are
concurrently regulated by a common miRNA.
In a bioinformatics study, the gene-gene interactions
controlling the human T helper cell differentiation process
were identified by coexpression network but many of which
would not be detected using differential expression [12].
Coexpressed genes tend to participate in the same regulatory
and signaling circuits, forming complexes, pathways, and
networkmodules [9, 13–16]. Further, strong coexpressionwas
proved to cohere with higher gene ontology (GO) similarity
and protein-protein interaction than that of random gene
pairs [12].
This study adopted a gene network analysis approach
based on coexpression measure. Correlation coefficient is a
scale-invariant statistic that can be applied to measure the
gene coexpression [17]. Two genes are linked if their corre-
lation exceeds a specific threshold. Some existing approaches
attempted to optimize the threshold with respect to the sta-
tistical significance of correlation or the network complexity,
but not to the overall coexpression profiles of the disease
and the normal states [12, 18]. Underlying mechanisms
of gene interaction can be deciphered by contrasting the
coexpression networks of the disease and the normal groups.
Chronic myelogenous leukemia (CML) is considered as
the disease of interest for gene network analysis. The dis-
rupted and invoked gene connections in CML represent the
impaired mechanism when compared with the healthy indi-
viduals. In CML, a number of mitogenic signaling pathways,
such as mitogen-activated protein kinase (MAPK) pathway
and janus kinase (JAK)/signal transducer and activator of
transcription (STAT) pathway, are activated so that the
pluripotent hematopoietic stem cells aberrantly proliferate
and differentiate to granulocytes in the blood [19]. The recip-
rocal translocation between chromosomes 9 and 22 results
in the oncoprotein expressed from the BCR-ABL fusion
oncogene and triggers the mitogenic signaling pathways.
Apoptosis and adhesion properties of hematopoietic progen-
itors are deregulated by BCR-ABL, leading to massive leaving
of immature progenitors from bone marrows [23]. The par-
ticipation of autophagy and the transcriptional and posttran-
scriptional regulations in the molecular mechanism altering
the progenitor cell functions is still unclear. This study is
aimed to compare the CML patients with the healthy indi-
viduals in terms of the balance control between apoptosis and
autophagy and identify the roles of TFs and miRNAs in the
control mechanism. The gene networks provide global inter-
actomic information to facilitate deeper understanding of
carcinogenesis and identification of efficacious drug targets.
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Table 1: List of selected genes, relevance, and supporting references.
HUGO gene symbol Relevance References
MCL1; BCL2; BAD Apoptosis; autophagy;CML [2, 19, 20]
BAX; BAK1 Apoptosis [1–3, 6]
E2F1; E2F2; E2F3; MYC Apoptosis; autophagy; cellcycle; CML [3, 6, 19, 21, 22]
PIK3R2; PIK3R3; PIK3R5; AKT1; AKT2; AKT3 Apoptosis; cell cycle; CML [19, 23–25]
ATG5; ATG7; ATG12; MAP1LC3B; BECN1 Autophagy [2, 5, 6, 26]
2. Methods
2.1. CML Dataset. The microarray dataset, analyzed in this
work, was provided by a study comparing the normal and the
CML hematopoietic stem/progenitor cells in gene expression
[27]. The study recruited eight (Philadelphia) Ph+ CML
patients and collected their peripheral blood. The bone
marrows of four healthy donors were purchased from private
sectors. The CD34+ cells were selected and sorted to G0 and
G1/S/G2/M fractions. There were eventually 24 samples (16
CML and 8 normal) after the sorting. Total RNA was isolated
from the cells of each sample, labeled, and hybridized to
Human Genome U133 plus 2.0 arrays. The dataset has been
deposited on theGene ExpressionOmnibus (GEO) under the
Accession number GSE24739 for public access.
Based on the relevance to apoptosis, autophagy, cell cycle,
and CML, twenty genes were selected for the coexpression
network analysis. Table 1 shows the human genome orga-
nization (HUGO) gene symbols of the selected genes and
the corresponding references supporting the relevance. This
work considered a small portion of the related genes because
it is aimed to differentiate the disease from the normal
patterns of functional linkages between the key mediators
and markers in molecular level.
2.2. Coexpression Measure. Coexpression between two genes
can be quantified by a measure evaluating how similar their
expression patterns are across the biological samples. The
scale invariant property of Pearson correlation coefficient
makes it a suitable choice for measuring the similarity
between the expression patterns [13, 17]. Let 𝑥
𝑖
and 𝑥
𝑗
and
cor(𝑥
𝑖
, 𝑥
𝑗
) be the expression profiles of the 𝑖th and 𝑗th
genes extracted from the expression matrix and the Pearson
correlation coefficient between them.The coexpression level,
𝐶(𝑖, 𝑗), was defined as in the formula (1) [17]:
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The absolute value was taken because the coexpression
measure will output a scalar in the range from 0 to 1 where
a high output indicated a strong biological relationship in
either positive or negative direction and a low output indi-
cated a weak biological relationship. Such implementation
ensured that the inhibiting molecular interactions, such as
degradation of MCL1 by beta-TrCP [28], can be detected
using this measure. The coexpression level was denoted
by 𝐶
𝑑
(𝑖, 𝑗) if two expression profiles were extracted across
samples of the disease (CML) group and 𝐶
𝑛
(𝑖, 𝑗) for the
normal group.
2.3. Threshold Selection. In this study, a network presented
genes as nodes and connected them with undirected edges
if their coexpression levels exceeded a particular threshold
value [12, 17]. In order to obtain two gene networks that char-
acterized and differentiated the disease and the normal states,
an optimal threshold of coexpression level was identified to
classify the gene pairs in the disease and the normal states into
strong and weak coexpression classes so that the classes were
best associated with the groups. Two-sample Kolmogorov-
Smirnov (KS) test was a good choice because it was sensitive
to the differences in the distributions of two samples, that is,
𝐶
𝑑
and 𝐶
𝑛
in this case, and gave a threshold value, at which
the deviation between the cumulative distribution functions
of 𝐶
𝑑
and 𝐶
𝑛
was the maximum [29]. Let 𝐹
𝑑
, 𝐹
𝑛
, and 𝐷 be
the cumulative distribution functions (CDFs) of 𝐶
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and 𝐶
𝑛
and the maximum deviation, respectively.The value of𝐷was
given by the following formula (2):
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Note that the inequalities inside the CDFs were inverted
because our interest focused on the strong coexpression
(Formula (3)).The optimal threshold (𝐶) represented a coex-
pression level, at which 𝐹
𝑑
and 𝐹
𝑛
were extremely deviated.
After the optimal threshold was identified, the gene pairs can
be bisected into two coexpression classes. Chi-square test was
also used to verify the association between the coexpression
class and the disease. Consider
𝐹
𝑑
(𝐶) = Prob (𝐶
𝑑
≥ 𝐶) ,
𝐹
𝑛
(𝐶) = Prob (𝐶
𝑛
≥ 𝐶) .
(3)
2.4. Gene Network Construction. For clearer illustration of
gene network, the identified gene pairs were classified into
common, normal-specific, and disease-specific connections.
The common connections were defined as the strongly
coexpressed pairs shared by both the disease and the nor-
mal groups. The disease-specific connections, that is, CML-
specific, were the strongly coexpressed pairs in the disease
group with the common connections removed. The normal-
specific connections were the strongly coexpressed pairs in
the normal group with the common connections removed.
Each type of connections can form a coexpression network
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having a particular biological meaning. The normal-specific
connections were the potential molecular interactions main-
taining physiological balance in healthy individuals. The
disease-specific connections represented the characteristics
of the disease.
A coexpression network consisted of genes connected
by edges. Pajek was used to analyze and visualize the coex-
pression networks because it supports the global and local
views of networks with various abstraction, visualization, and
algorithmic tools [30]. Further, the coexpression levels were
transformed and input along with the gene pairs to Pajek so
that their values can be reflected by the edge thicknesses in the
network. To display edges with thickness from 1 to 6 points,
the coexpression levels between the threshold value and the
maximum value were linearly transformed to the range from
1 to 6. Thus, the thicker edges could catch more attention in
the visualization.
2.5. Identification of Regulatory Signatures. Composite reg-
ulatory signature database (CRSD) is a bioinformatic web-
based resource, which integrates UniGene, mature miR-
NAs, putative promoter, TRANSFAC, pathway, GO, miRNA
regulatory signature (MRS), and TF regulatory signature
(TRS) databases to facilitate the comprehensive analysis of
gene regulation networks [31]. MRS is defined as a set of
interactions between a miRNA and a group of genes with
its putative targets in the 3󸀠 UTR. TRS is defined as a set
of interactions between a TF and a group of genes with
its putative binding sites in the 5󸀠 UTR. Combining MRSs
and TRSs of a common group of genes yields the composite
regulatory signature (CRS). CRSD was used to query the
MRS, TRS, or CRS for the strongly coexpressed gene pairs.
The identified signatures can help to explore how the TFs
and miRNAs drive the normal-specific, disease-specific, and
common gene coexpression patterns.
3. Results
3.1. Thresholds of Coexpression Levels. Among 20 genes con-
sidered in this work (see Table S1 in Supplementary Material
available online at http://dx.doi.org/10.1155/2015/459840), the
coexpression levels of 190 gene pairs were computed for
the normal group and the CML group independently. Gene
pairs can be dichotomized into strong andweak coexpression
classes, which characterized the corresponding groups. The
threshold for the dichotomy was determined by two-sample
KS test. The CDFs for the normal and the CML groups
were numerically evaluated at every possible threshold value
from 0 to 1 (Figure 1). It was found that the evaluated
cumulative fractions were optimally deviated by 𝐷, 0.2789,
at the coexpression level 𝐶, 0.4233 (optimal threshold). The
KS test indicated that the two distributions were significantly
different (𝑃 value < 0.01 for the statistic 𝐷 = 0.2789). The
contingency table of the gene pair counts at the optimal
threshold is shown in Table 2. At the optimal threshold, the
dichotomy of gene pairs was significantly associated with
the disease as the Chi-square statistic was 31.4957 (𝑃 value
< 0.01). The differential coexpression distribution suggested
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Normal group
CML group
Optimal threshold
Fd(C)
Fn(C)
D
Coexpression level, C
Cu
m
ul
at
iv
e d
ist
rib
ut
io
n 
fu
nc
tio
n,
F
Figure 1: Cumulative distribution functions of coexpression levels
for the normal and the CML groups with the candidate thresholds
from 0 to 1.
Table 2: Contingency table of gene pair counts at the optimal
threshold.
Class CML Normal
Strong coexpression 45 98
Weak coexpression 145 92
that the genes related to apoptosis and autophagy, in overall,
exhibited more robust functional links in the normal group
than the CML group.
3.2. Gene Networks. TheCML and the normal groups shared
27 common strongly coexpressed gene pairs according to the
optimal threshold. After removing the common gene pairs
from the strong coexpression class, the normal-specific gene
pairs comprised 71 pairs and the CML-specific comprised
18 pairs. The coexpression networks for the normal-specific,
CML-specific, and common gene pairs were constructed as
shown in Figure 2.
3.3. Regulatory Signatures. By querying the regulatory sig-
natures in CRSD, the miRNAs and TFs predicted to target
the normal-specific and the CML-specific gene pairs were
identified. To maintain the significance of the identified
regulatory signatures, amiRNAor TFwas selected for further
investigation if it targeted no less than four gene pairs. It was
found that each of hsa-miR-504 and hsa-miR-125a concur-
rently regulates the expression of four genes in the normal-
specific coexpression network, forming two MRSs. As the
two MRSs shared two common genes, BAK1 and BCL2, they
were combined to form the normal-specific MRS network
(Figure 3(a)). It was also found that each of zinc finger protein
(AP-4) and E2F concurrently regulates the expression of five
genes, and vitamin D (1,25-dihydroxyvitamin D3) receptor
(VDR) concurrently regulates the expression of four genes in
the normal-specific coexpression network. As the three TRSs
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Figure 2: Coexpression networks (Using Pajek).Thenodes represent genes.The edges indicate the strong correlation between nodes.The edge
thickness reflects the coexpression levels. (a) Normal-specific coexpression network. (b) CML-specific coexpression network. (c) Common
coexpression network.
shared E2F2 as the common target gene, they were combined
to form the normal-specific TRS network (Figure 3(b)). The
connections coincided in the normal-specific MRS and TRS
networks were the triangle linking E2F2, BAK1, and PIK3R5.
These all three connections had strong coexpression levels
and formed the normal-specific CRS network with AP-4 and
hsa-miR-125a (Figure 3(c)).
In the CML-specific network, each of the identified
miRNAs and TFs targets not more than two gene pairs. The
MRS and TRS were not considered for further investigation
because they were not so informative to suggest the concur-
rent regulations. Instead, it is interesting to note that E2F3
was linked to v-aktmurine thymomaviral oncogene homolog
3 (AKT3) directly and v-myc avian myelocytomatosis viral
oncogene homolog (MYC) indirectly, and these three genes
are the predicted targets of hsa-miR-15a, hsa-miR-15b, hsa-
miR-34c, and hsa-miR-342. Further, E2F3 and BCL2 were
found to be strongly coexpressed, which are the predicted
targets of E2F1:DP-2 and E2F4:DP-2. Among these genes,
E2F3 is predicted to be coordinately regulated by four
miRNAs and two TFs. These connections were combined to
form the CML-specific E2F3 regulatory signature (E2F3-RS)
network (Figure 3(d)).
4. Discussion
4.1. Disease-Associated Coexpression Threshold. Protein
encoded by a gene performs its functions through the molec-
ular interactionswith that of the other genes.Without consid-
ering its functional partners, the expression level and differ-
ential expression of a gene are not informative enough to
indicate whether it performs its known functions. Coex-
pression level between two genes quantifies the extent, in
which the change in expression level of a gene coincides with
that of the other. There may not be a coexpression threshold
that can indicate the molecular interactions of two genes, but
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Figure 3: Regulatory signature (RS) networks. (a) Normal-specificMRS network. (b) Normal-specific TRS network. (c) Normal-specific CRS
network. (d) CML-specific E2F3-RS network.
a threshold exists for identifying the strongly coexpressed
gene pairs to optimally differentiate the normal and the
disease groups in terms of the functional linkages. In our
study, more strongly coexpressed gene pairs were found in
the normal group than the CML group (Table 2). It implied
that many functional links between genes, which may react
to the external factors to further maintain the proper cellular
functions or the tissue homeostasis in the normal group,
were impaired in the CML group. The impaired connections
may provide useful information for understanding the
underlying molecular interaction mechanism and exploring
the novel drug targets of CML.
4.2. Functional Coexpression Patterns. Genes highly con-
nected with other genes act as the hubs for relaying the adap-
tive changes in gene expression through the molecular inter-
actions. In the normal-specific network (Figure 2(a)), E2F1,
E2F2, and E2F3 established, respectively, 11, 13, and 9 con-
nections with other genes, implicating their central roles in
the proper regulation of apoptosis, autophagy, and cell cycle.
E2F1, E2F2, and E2F3 activate the cell cycle progression and
drive the cells from quiescent (G0) into synthesis (S) phase
[32]. The interplay of E2F1, E2F2, and E2F3 with other genes
in the network maintained the balance between cell death,
survival, and proliferation. Three remarkable coexpression
patterns connected by E2F1, E2F2, and E2F3 were found in
the normal-specific network and further discussed as follows.
In the normal-specific network, E2F2was connected with
BAK1, PIK3R5, and AKT3 in the high coexpression levels
(correlation coefficients were 0.701, 0.778, and −0.756, resp.).
BAK1 is a proapoptotic molecule. The positive correlation
implied that when E2F2 was upregulated to speed up the
cell cycle for the cellular proliferation, BAK1 may respond
with the upregulation to promote apoptosis to control the cell
number. We also revealed that PIK3R5 was an essential hub
with 10 connections in the network. PIK3R5 is a regulatory
subunit, which combines with a catalytic subunit to form the
class I PI 3-kinase (PI3K). Since the PI3K pathway contributes
to antiapoptosis and cell survival, E2F2 and PIK3R5 may
be activated by RAS to promote the proliferation in the
normal group [33]. In the common coexpression network
(Figure 2(c)), PIK3R5 and AKT3 were strongly coexpressed
in both two groups, but the correlation coefficients for the
normal and the CML groups were of opposite signs (normal:
−0.802; CML: 0.757). It implicated that the activation of
AKT3 by PI3K may be retarded by the 3󸀠-phosphoinositide
phosphatase (PTEN) in the normal group so that the growth
signal could not be relayed to mTOR signaling pathway and
thus autophagy was possibly allowed [6, 34]. In contrast, the
PI3K/AKT signaling may repress autophagic response in the
CML group so that the damaged organelles could not be
degraded. The negative correlation between E2F2 and AKT3
implied that the proper autophagy could be maintained
during the cell cycle progression in the normal group. From
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the above observations, we can hypothesize that E2F2 favors
both apoptosis and autophagy.
The normal-specific network showed that E2F1 was
connected with ATG5, ATG7, ATG12, BCL2, and MYC in
the high coexpression levels (correlation coefficients were
−0.708, 0.883, −0.627, 0.954, and 0.642, resp.). ATG5 and
ATG12 are involved in the vesicle elongation of the autophagy,
while ATG7 helps the covalent conjugation of ATG5 and
ATG12 [5]. During the cell proliferation, autophagy may be
partially inhibited, as ATG5 and ATG12 are downregulated at
the early stage of autophagy, but their covalent conjugation
is readily facilitated by the upregulation of ATG7. BCL2
inhibited the apoptosis during cell cycle progression as its
expression was positively correlated with E2F1 in the normal
group. The positive correlation between E2F1 and MYC is
supported by the mutual induction of gene expression [35].
MYC is a proapoptotic molecule. The antiapoptotic and
proapoptotic responses of BCL2 and MYC coexisted in the
normal-specific network because they can activate different
pathways. BCL2 regulates the release of cytochrome c and
caspase activation and then inhibits apoptosis [1–4]. MYC
triggers the p53 signaling pathway to induce cell death when
DNA damage happens [36]. It is hypothesized that E2F1
linking to various genes can promote and inhibit apoptosis
through different pathways and partially links to autophagy.
It was shown in the normal-specific network that MCL1,
BAX, and beclin-1 (BECN1) were connected with E2F3 in
the high coexpression levels (correlation coefficients were
−0.876, −0.957, and −0.804, resp.). BAX and BECN1 can
promote apoptosis and autophagy, respectively, [1, 3, 5].
The negative correlation implied that both apoptosis and
autophagy were inhibited when E2F3 was upregulated during
the cell proliferation. MCL1 expression was also negatively
correlated with E2F3. The hematopoietic cells may not be
so sensitive to the stress as MCL1, a stress sensor, was
downregulated during the cell cycle progression. Conversely,
these three geneswere upregulated to promote autophagy and
apoptosis when the cells were situated in the G0 phase. In
contrast, MCL1, BAX, and BECN1 were strongly coexpressed
with each other without the participation of E2F3 in the
common coexpression network (correlation coefficients of
BECN1 and MCL1, BAX and MCL1, and BAX and BECN1
were 0.607, 0.831, and 0.895, resp.). The results demonstrated
the persistent interplay between apoptosis and autophagy.
In all, we can hypothesize that E2F3 opposes against both
apoptosis and autophagy.
In the CML-specific network (Figure 2(b)), E2F3 and
AKT3 were connected with a positive correlation (0.660).
Though E2F3 opposed autophagy again as in the normal
group, AKT3 responded to oncogenic or endoplasmic retic-
ulum stress that were different from the stress detected by
MCL1 [34].
4.3. Regulatory Mechanisms. The hsa-miR-504 and hsa-miR-
125a MRSs shared the BAK1 and BCL2 connection as a com-
mon link in the normal-specific MRS network (Figure 3(a)).
The balance between the proapoptotic and antiapoptotic
properties of BAK1 and BCL2 was supported by their positive
correlation (0.696), which may be induced by the coordinate
regulation of hsa-miR-504 and hsa-miR-125a.
Three normal-specific TRSs were observed where VDR,
E2F, and AP-4 are predicted as the TFs (Figure 3(b)). Again,
E2F2 was the hub at the center of the TRSs and concurrently
targeted by the three TFs. The E2F TRS concurred with the
autoregulatorymechanismof E2F family proteins in cell cycle
regulation. It was illustrated that the gene silencing of AP-4 is
able to trigger apoptosis [37]. Apoptotic regulatory roles of
AP-4 were further justified by the fact that the genes related
to apoptosis, BAK1, BAD, PIK3R2, and PIK3R5, are predicted
to be its targets.
It was straightforward to observe a motif shared by the
MRS and TRS networks, that is, the CRS consisting of E2F2,
BAK1, and PIK3R5 (Figure 3(c)). The correlation coefficients
between themwere positive and high (E2F2 and BAK1: 0.701;
E2F2 and PIK3R5: 0.778; BAK1 and PIK3R5: 0.913). Through
the coregulation byAP-4 and hsa-miR-125a, these three genes
established a tight balance between cell death and survival
when the cell proliferation was activated.
In Figure 3(d), E2F3 is predicted as the common target
of four miRNAs and two TFs. The TFs and miRNAs were
found to be counteracted to control the expression level of
E2F3. It was proved that the deletion ofmiR-15 was frequently
found in chronic lymphocytic leukemia (CLL) [38]. It is
anticipated that the overexpression of E2F3 caused by the
deletion of miR-15 may induce myeloid malignancy. Further,
the miRNAs, including miR-15a, downregulated both E2F3
and AKT3 and maintained their strong coexpression in the
CML group. These evidences further justify that E2F3-AKT3
connection may be CML-specific.
5. Conclusion
Gene network analysis helps us to explore the gene connectiv-
ity and the potential functional linkages. This work adopted
an approach for identifying the gene pairs with strong
coexpression classified by a disease-associated threshold.
CML was the disease of interest in this work. The normal-
specific network illustrated the gene connections found in
the proper cellular regulation but not in cancer molecular
mechanism. As the key transcription factors of cell cycle
regulation, E2F1, E2F2, and E2F3, acted as the hubs for
the normal-specific connections. E2F1 was associated with
antiapoptosis and proapoptosis through different pathways
but partially associated with autophagy. E2F2 was linked
with the promotion of apoptosis and autophagy, while E2F3
exhibited opposition to apoptosis and autophagy. In the
CML-specific network, the link between E2F3 and AKT3
demonstrated a possible cellular response to oncogenic stress
in the proliferation of hematopoietic cells. It is important
to note that E2F3 and AKT3 are both the predicted targets
of miR-15, whose deletion was proved to be associated with
cancer. The coregulations of genes by miRNAs and TFs were
indicated by theMRS, TRS, andCRS.The central role of E2F2
was further confirmed by the normal-specific TRS network.
In the normal-specific MRS network, the apoptotic balance
was strengthened by the coregulation of BAK1 and BCL2 by
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miRNAs. As a normal-specific CRS, the E2F2-BAK1-PIK3R5
motif may constitute the core mechanism controlling the cell
cycle progression, apoptosis, and autophagy, which requires
further investigation in the future experimental studies.
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